Showing 1 - 2 results of 2 for search 'William R. Spreen', query time: 0.02s Refine Results
  1. 1
    Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine

    Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine by Parul Patel, Paula Teichner, Emilie Elliot, Marta Boffito, Milena Murray, Joseph W. Polli, Mark Baker, Susan L. Ford, Kelong Han, Alberto Russu, Herta Crauwels, Ronald D. D’Amico, William R. Spreen, Jean van Wyk

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.

    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. by Raphael J Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron

    Published 2018-11-01
    Get full text
    Article

Search Tools: